Evita Harfst

Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study

Peter Rich, Bárður Sigurgeirsson, Diamant Thaçi et al. · British Journal of Dermatology · 2013 · 244 citations

Life Sciences, Dermatology, Immunology +17

Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomised, double-blind, placebo-controlled, phase II regimen-finding study

Peter Rich, Bárður Sigurgeirsson, D. P. Thaci et al. · British Journal of Dermatology · 2012 · 189 citations

Life Sciences, Dermatology, Immunology +17

Secukinumab improves hand, foot and nail lesions in moderate‐to‐severe plaque psoriasis: subanalysis of a randomized, double‐blind, placebo‐controlled, regimen‐finding phase 2 trial

C. Paul, Kristian Reich, Alice B. Gottlieb et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 83 citations

Medicine, Dermatology, Pharmacotherapy +17

The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women

Sibylle P. Hämmerle, Linda Mindeholm, Aino Launonen et al. · Bone · 2012 · 43 citations

Medicine, Pharmacokinetics, Pharmacology +11

AXT914 a novel, orally-active parathyroid hormone-releasing drug in two early studies of healthy volunteers and postmenopausal women

Markus R. John, Evita Harfst, Juergen Loeffler et al. · Bone · 2014 · 37 citations

Medicine, Endocrinology, Pharmacology +7